
























































MEDICINE published: 29 January 2015doi: 10.3389/fmed.2014.00060
Optimizing care and outcomes for people with type 2
diabetes – lessons from a translational research program
on insulin initiation in general practice
John Furler 1*, Irene Blackberry 1,2, Jo-Anne Manski-Nankervis1, David O’Neal 3, James Best 4 and
DorisYoung1
1 General Practice and Primary Health Care Academic Centre, The University of Melbourne, Carlton, VIC, Australia
2 John Richards Initiative, School of Nursing and Midwifery, La Trobe University, Wodonga, VIC, Australia
3 Department of Medicine, St Vincent’s Hospital, The University of Melbourne, Fitzroy, VIC, Australia
4 Melbourne Medical School, The University of Melbourne, Parkville, VIC, Australia
Edited by:
Aline Ramond-Roquin, University of
Angers, France
Reviewed by:
Harm Van Marwijk, VU University
Medical Centre, Netherlands
Yoann Gaboreau, Université Grenoble
Alpes, France
*Correspondence:
John Furler , Department of General
Practice, University of Melbourne,
200 Berkeley Street, Carlton, VIC
3053, Australia
e-mail: j.furler@unimelb.edu.au
Background: Clinical inertia, failure to intensify treatment according to evidence-based
guidelines, leads to prolonged, avoidable hyperglycemia in people with type 2 diabetes
(T2D). This is a challenge for General Practice and Primary Care, where most people with
T2D receive most of their care. Sustained, integrated translational research programs are
needed to embed effective treatments in routine practice, yet many challenges exist for
developing such programs.
Objectives:To explore challenges and facilitators to implementing a translational research
program focused on insulin initiation and titration among people with T2D in general prac-
tice and to identify key factors important to support and sustain such translation research
in primary care.
Operationalizing a program of translational work in primary care:We describe a series
of studies on insulin initiation and titration in general practice including theory and qualita-
tive work (Phase 1), a small feasibility and acceptability pilot (Phase 2), a large scale pilot
(Phase 3), and a pragmatic cluster randomized trial currently under way (Phase 4). We used
mixed methods to explore practice level implementation issues, and reflective investigator
discussions to explore broader research program sustainability.
Challenges for translational research in primary care: Key facilitators and barriers at
practice and research program levels, include: Appropriate funding structures to secure
long-term capacity building and people support; Building and maintaining linkages between
communities of practice, primary and secondary/tertiary care researchers, institutions, and
industry partners; Strategies for engagement and support for practitioners and participants.
Conclusion: Building effective and sustainable translational research programs are critical
for developing evidence-based policy that drives improved outcomes at a population level.
Diverse sources of funding that support extensive and sustained trans-mural collaboration
as well as engagement with practitioners, patients, and policymakers in the field are crucial.
Keywords: general practice, insulin, translational medical research, primary nursing, diabetes mellitus, type 2
INTRODUCTION
The rising global epidemic of type 2 diabetes (T2D) places primary
care at the frontier of an effective health-care response. Implemen-
tation of evidence-based treatments in primary care, where most
patients receive almost all of their diabetes care, can for example
help patients achieve glycemic targets early in their illness, which
is important for improving long-term patient outcomes. Yet, most
people in the community with T2D continue to have glycemic
levels out of target.
Insulin is an evidence-based treatment for achieving nor-
moglycemia in T2D. Use of long acting insulin analogs with
patient-driven algorithms is feasible, safe, effective (1, 2), and asso-
ciated with improved patient satisfaction (3). Early use of insulin
for people with T2D is supported by international guidelines (4).
Yet, starting insulin is often delayed in clinical practice, particularly
in general practice leading to prolonged hyperglycemic burden for
patients (5).
This is an example of a “translational gap.” Bridging such gaps
to improve research impact in the real world of clinical care is a
global issue. It is the focus of Clinical Translation Science Centres
in the US (6), the National Institute of Health Research in the UK
(7), and the Research Translation Faculty in the National Health
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and Medical Research Council (MRC) in Australia. All these initia-
tives aim to bridge the “valley of death” between research evidence
and health policy and clinical practice.
The “T3 translational gap” covers “Translation to Practice” and
is focused on ways to disseminate and implement recommenda-
tions from clinical efficacy studies into general clinical practice. T3
translational research is particularly important for primary care,
where the“grand challenge”(8) is to design studies that account for
primary care’s unique context, the uncertainty and the generalist
approach that are at the heart of primary care practice.
There is now a growing science of implementation (9, 10).
The MRC framework for the development and implementa-
tion of complex health services interventions supports a stepwise
approach, based on theory to guide the development of clinically
relevant interventions and their implementation in real-world
practice (11).
There are numerous reports of individual translational studies,
but few descriptions of sustained programs of linked translational
studies. We describe a program addressing the translational gap
around insulin initiation in general practice for people with T2D
who have glycemic levels out of target. The details of each of the
component studies have been reported elsewhere. Our aim in this
paper is to illustrate the use of the MRC framework in operational-
izing a sustained program of T3 translational research in primary
care. Our second aim is to identify factors important to supporting
and sustaining such translational research in this setting.
OUR PROGRAM OF WORK
RETHINKING INSULIN INITIATION: THE CONTEXT FOR OUR WORK
It makes sense to base insulin initiation for people with T2D in
routine general practice. Metabolic control in diabetes is often
just one facet of managing multiple co-morbidities, so integrat-
ing a patient’s diabetes care with care for other conditions seems
important. This could also reduce costs and be more acceptable to
patients.
The reasons that many people with T2D do not have glucose
levels within target are complex. Patients and clinicians struggle
with the complex, progressive nature of this condition. Constant
monitoring, adjustment and intensification of lifestyle, and med-
ications are needed. For clinician and patient, the challenges asso-
ciated with caring for and living with such a complex and dynamic
chronic condition (12) may underlie practitioner “clinical inertia”
(13). Delayed initiation of insulin may also stem from patients
“psychological insulin resistance” (14). Health system and orga-
nizational factors are also important. For example, people with
T2D are commonly referred to specialist care for insulin initiation
(15, 16). Where general practice acts as a “gatekeeper,” difficulties
accessing endocrinologists and diabetes nurse educators (DNEs)
due to cost and limited availability can cause delays. Intermediate
care, outreach clinics, and special interest practitioners (17) have
all been suggested as ways to address this. Yet, gaps in treatment
and achievement of targets persist.
This complex clinical problem is the focus of our research
program (Figure 1). Consistent with the MRC framework, we
began with an exploratory qualitative study (18), leading to the
development of a practice-based intervention tested for feasibil-



















Theory of implementation: Normalisation Process Theory
FIGURE 1 | Program of work and underpinning theory.
leading to a cluster randomized controlled trial (RCT) (21), the
final outcomes for which are expected in mid-2015.
Each study included its own evaluation, appropriate to the level
of the study. Each study was approved by the Human Research
Ethics Committee of Melbourne University. A core group of inves-
tigators, including a patient representative has been involved in
each of the studies, with additional investigators added as the size
and complexity of the studies increased.
THEORETICAL BASIS FOR A TRANSLATIONAL RESEARCH PROGRAM
Rather than using psychological theories of behavioral change,
we based our work on normalization process theory (NPT)
(see Figure 1), a sociological theory of implementation, which
describes how new practices become incorporated into routine
clinical care as a result of individual and collective work (9). NPT
describes how, a new practice becomes “normalized” as the peo-
ple involved make sense of it, engage with and invest in it as they
work, understand and agree who is involved in the new practice,
and reflect on how the work is going.
Normalization process theory suggested that developing our
research program would need patient representation as well as
all members of the multidisciplinary diabetes team, including
endocrinologist, DNE, general practitioners (GP), and generalist
practice nurses (PNs). In Australia, most practices employ at least
one PN (22), and they play an important role in chronic condition
care, although not to the extent seen in countries such as the UK.
All of these groups are involved in the “work” of insulin initiation.
OPERATIONALIZING A TRANSLATIONAL PROGRAM OF
RESEARCH IN GENERAL PRACTICE
STUDY 1: UNDERSTANDING THE WORK INVOLVED IN INSULIN
INITIATION IN GENERAL PRACTICE
A qualitative study (14) explored GPs and DNEs stories of“success”
and “failure” in initiating insulin from their own practice while
patient interviews used an illness narrative approach (23). This
study captured the social, inter-professional, and organizational
scaffolding of diabetes work that surrounded this key therapeutic
moment. We identified a contrast in how people understood the
aim of diabetes care in general practice (caring for disease ver-
sus caring for person), which shaped their perception of insulin
initiation. While we identified uncertainty about who was seen
as responsible for starting insulin, patients valued any profes-
sional willing to work on issues the patient themselves considered
important.
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Our findings suggested that a key challenge lay in supporting
the integration of the technical work of insulin initiation with the
generalist work structures and relational ethos of general practice
through:
1. A clear and workable, in-practice system for referral and
delegation of clinical work to integrate insulin initiation
within the busy, reactive, time-pressured day-to-day GP clinical
work;
2. Clarifying and acknowledging the aims and objectives of dia-
betes care from both the patient and clinician perspective;
and
3. Clarifying the roles of GP, PN, DNE, endocrinologist, and
patient in initiating insulin.
STUDY 2: A MODEL OF CARE WITH AN ENHANCED ROLE FOR THE
PRACTICE NURSE – THE “STEPPING UP PROGRAM”
Based on Study 1, we developed an intervention model of care
explicitly incorporating an enhanced role in insulin initiation for
the generalist PN (19). This enhanced role acknowledged the busy
workflow of day-to-day practice and was designed such that GPs
could delegate an active role for the PN to introduce and discuss
the idea of insulin initiation with patients. While GPs retained pre-
scribing authority,our model of care was based on the existing rela-
tionship between patients and GP–PN teams and allowed the pos-
sibility for in-house commencement of insulin, avoiding the need
for referral and associated delays. Our intervention incorporated
practitioner education [using simple, understandable evidence-
based tools and algorithms for basal glargine insulin initiation and
titration (1)], in-practice system change and minimal phone-based
mentoring/support for the PN from a DNE and endocrinologist if
needed.
The training and intervention resources were pragmatic, having
been developed by GP and other primary care researchers. They
acknowledged the multiple competing priorities in general prac-
tice and the need to tailor management to the individual patient
and provider circumstances.
After a pilot of this model of care in five practices, qualita-
tive evaluation involved workshops, focus groups, and interviews
for clinicians and patients. Sustained use of the model in prac-
tice beyond the pilot suggested acceptability and generalizability.
We found examples of how features of generalist practice were
mobilized to the technical task of initiating insulin. For exam-
ple, continuity of therapeutic relationships over time, biographical
knowledge of patients, and whole person care were used proac-
tively within the work of insulin initiation. Patients were able
in this way to engage with the work of starting insulin in their
own time and on their own terms. GPs and PNs saw this as
coherent and meaningful work and that the model of care, tools,
and resources supported “collective action” to address this gap in
practice.
Challenges we identified included the need to continuously
negotiate clinical autonomy at a local practice level, based on a
shared understanding of scope of practice for PNs. There was
concern about the lack of structural financing for the PN time
involved in this work if it were to be scaled up at a practice
level.
STUDY 3: FIELD TESTING THE MODEL OF CARE MORE WIDELY
A larger pilot (20) in collaboration industry partners involved a
non-randomized study of the model of care in 22 practices and
92 patients. We nested a study of retrospective continuous glucose
monitoring (rCGM) within this pilot. Evaluation using a before
and after design found a significant fall in HbA1c (24).
This study identified an evolution in the nature of the inter-
vention model of care. The need for more intensive study DNE
involvement with PNs and patients because of the embedded
rCGM study partly changed the intervention. The model of care
now included more DNE support for PNs on a face-to-face basis,
rather than minimal phone support. We also incorporated more
structured titration tools, including the addition of glulisine (short
acting) insulin at one meal time if needed.
STUDY 4: EVALUATING THE OUTCOMES OF THE MODEL OF CARE
Our current cluster RCT (21) involves 75 practice and 266 patients,
randomized at the practice level to receive the model of care inter-
vention or usual general practice care. Follow-up data collection
will be completed by March 2015.
This trial has allowed flexibility and a tailored approach in
the implementation of the intervention, particularly relating to
the level of DNE support. The study DNE has spent significant
face-to-face time supporting PNs in some practices to embed and
normalize the intervention, while other practices have required
minimal support post-training. Evaluation has included inter-
views with GPs and PNs, which will be extended to patients as
the trial is completed.
CHALLENGES FOR TRANSLATIONAL RESEARCH IN PRIMARY
CARE
Changing clinical practice involves understanding and responding
to the complex social and clinical milieu within which GPs, prac-
tice staff, and patients work. This has required a sustained and
iterative process of development, implementation, and evaluation
guided by the MRC framework.
USING THE MRC FRAMEWORK AS GUIDANCE IN DESIGNING,
IMPLEMENTING, AND SUSTAINING OUR INTERVENTION
Addressing perceived needs of patients and providers
One important issue in implementing a new complex practice is
“fit” with the perceived needs of those practitioners and patients
who are expected to take up the new practice. This is the “sense
making” domain of NPT. One way to try to match an intervention
to the needs and preferences of end users is to explicitly incorpo-
rate options and preferences as part of an intervention (25). Our
method of trying to achieve “fit” with the needs of end users was
to use the MRC framework to guide an iterative process of con-
sultation and intervention adaptation in our overall program of
work, similar to the way Barley and colleagues describe the devel-
opment of their intervention for depression in patients with heart
disease (26). In addition, while our model of care intervention did
not explicitly include patient preference and options as a formal
element of the intervention, we assumed that patient preferences
would be active elements within the routine clinical care provided
to them. In other words, we aimed to engage patients for whom
insulin was an appropriate clinical option for GPs to consider, and
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to provide GPs and PNs with the skills, and confidence and sys-
tems in their practice to discuss this with patients and to act on
this if the patient decided to give that treatment option a try. In
fact, a number of patients in our pilot studies and in our current
RCT chose not to start insulin.
Addressing inter-professional tensions
One element of meeting the needs of users lay in addressing inter-
professional tensions as the program of work evolved. This tension,
which emerged in our early qualitative work, centered on percep-
tions that the professional expertise and scope of practice of DNEs
was being challenged by the new model for insulin initiation in
general practice (27). This became evident in encounters between
the investigator and research staff (with backgrounds as GP, DNE,
endocrinologist, and PN) and clinical DNEs in the field, at a range
of meetings where both PNs and DNEs were attending and at
which our work was discussed.
Addressing this required a sustained communication of the
ethos and nature of our intervention and building genuine inter-
professional bridges. This included presentations at conferences
and meetings giving opportunity for stakeholders to engage and
identify goals we held in common. Critical to this dialog, and con-
sistent with a key T3 translational principle (28), has been ensuring
an investigator and research team composed of a patient represen-
tative and active “clinician researchers” that included all of the key
professional groups and able to speak credibly with clinicians in a
range of settings.
An adaptable and flexible intervention
The MRC framework notes that the framework stages may“. . . not
follow a linear or even a cyclical sequence” (11). Chambers et al.
(10) highlight that an intervention is never finally optimized but
rather continuously in development and is potentially enhanced
and strengthened while being implemented in real-world prac-
tice. If a research team is open and able to accommodate learnings
from the field in iterative cycles of design, implementation, and
evaluation, this can mean an intervention can evolve, approaching
greater coherence and fit (9) with routine practice in the field.
This was a helpful guidance for our work, where the amount of
DNE face-to-face support varied over the studies to achieve a flex-
ible hybrid in the current study where this is individualized and
tailored to the GP and PN needs. This is consistent with the way
the model of care would likely work in a post-trial state, where
a central organization provided DNE consultancy services that
varied in reach and uptake, in part determined by practice need.
This would require careful monitoring to identify unmet need. We
found that some practices used our flexible delivery approach to
delegate routine diabetes care to the study DNE. Some degree of
negotiation from the study DNE was needed to ensure appropriate
support and engagement was achieved.
Dove-tailing research with day-to-day general practice work
The guidance provided by the MRC framework helped us to evolve
our intervention to overlay the busy work of day-to-day general
practice as a “minimally disruptive” intervention. We wanted to
place few demands on practices in recruitment and data collection
while allowing them to set their level of their engagement with
an intervention increasingly adapted to the realities of practice.
Continuous engagement with practices, some of whom have con-
tinued involvement from study to study, has been built through
personal relationships, retaining clinically trained research staff
and use of regular newsletters and communications with our com-
munity of clinicians and patients. This needs significant resources
and staff continuity.
SUPPORTING AND SUSTAINING T3 TRANSLATION RESEARCH IN
PRIMARY CARE
Sustaining a coherent and cohesive research team, with junior and
senior clinician researchers, from primary and secondary care,over
a period time to allow the development of a research idea through
the stages of the MRC framework has been an important base for
this work.
In UK, this is recognized as a priority in the calls for “. . .
funding opportunities . . .encouraging interdisciplinary working;
. . . opportunities at the interface of medicine, public health and
social care; . . . supporting emerging research groups, new mod-
els and methodologies” (11). In our case, without a commitment
from funding bodies to support the stepwise approach of the
MRC framework, we needed to opportunistically source funds
from mainstream research councils, government tenders, NGO
and professional groups, and industry sources to support people
and field work.
This can mean stretching and diverting the focus of work to fit
with research priorities in currently available funding streams, an
opportunity cost that can threaten research intensity and quality
and staff continuity. Our experience is illustrative, supporting the
MRC call for “greater investment in developmental studies prior
to large scale evaluations, and in implementation research [which]
will help to ensure a better return on investment in evaluation
studies” (11).
CONCLUSION
Sustaining a linked program of translational research in general
practice and primary care is challenging work. It is challenging to
researchers as their theories and interventions struggle to match
the complexities of practice. It is challenging to funders to rec-
ognize the way flexibility, innovation, and co-creation involving
patients and practitioners are necessary to generate research that is
relevant, to optimize interventions, and to really support changed
practice across a range of settings and participants (10, 29). The
challenge for primary care practitioners and researchers is to advo-
cate and argue for the funding and support structures to foster such
open innovation.
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